E-DRUG: Prevalence of counterfeit medications in Pakistan (2)
-------------------------------------------------------------
Last week I had an interesting discussion with a well-respected staff
member at the US Senate and a former senior US FDA official about the
shortage of empirical and transparent data on prescription drug
counterfeiting. We should not base policy decisions on anecdotes. If
anyone on the list is aware of good empirical research on this issue
(the actual incidence of Rx counterfeiting), please send it to me,
either on-list or off-list. I will compile the responses and make it
available.
Kevin Outterson
Associate Professor of Law
West Virginia University
304 293 8282
kevin.outterson@mail.wvu.edu
LL.M. (Cantab.)
J.D. (Northwestern)
SSRN Author Page: ssrn.com/author=340746